Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCsStudy of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Do ...
A Multicentre, Late Phase Clinical Trial to Establish the Efficacy and Safety of Repeat Dosing of Autologous Endothelial Progenitor Cells (EPCs) Transfected With Human Endothelial NO-synthase (eNOS) in Patients With Pulmonary Arterial Hypertension (PAH) on Top of Conventional Treatments A Multicentre, Late Phase Clinical Trial to Establish the Efficacy and Safety of Repeat Dosing of Au ...
Hypertension,Pulmonary
Biological: Placebo followed by AutologousEPCstransfected with human eNOS;Biological: AutologousEPCstransfected with human eNOS followed by Placebo;Biological: AutologousEPCstransfected with human eNOS Biological: Placebo followed by AutologousEPCstransfectedwith human eNOS;Biological: AutologousEP ...
Pulmonary Hypertension: Assessment of Cell Therapy
Phase I Trial to Establish Safety of Autologous Progenitor Cell-based Gene Therapy Delivery of heNOS in Patients With Severe Pulmonary Arterial Hypertension(PAH)Refractory to Conventional Treatment Phase I Trial to Establish Safety of AutologousProgenitor Cell-based Gene Therapy Delivery of heNOS ...
Hypertension, Pulmonary
Biological: eNOS transfectedEPCs will be delivered via a PA line
Northern Therapeutics
St. Michael's Hospital, Toronto;Sir Mortimer B. Davis - Jewish General Hospital;St. Michael's Hospital, Toronto;Sir Mortimer B. Davis - Jewish General Hospital St. Michael's Hospital, Toronto;Sir Mortimer B. Davis - Jewish General Hospital;St. Michael's Hospit ...